In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of CorMedix Inc (NASDAQ: CRMD) closed at $14.97 in the last session, down -4.77% from day before closing price of $15.72. In other words, the price has decreased by -$4.77 from its previous closing price. On the day, 1.43 million shares were traded.
Ratios:
We take a closer look at CRMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 4.21. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 07, 2025, initiated with a Outperform rating and assigned the stock a target price of $18.
On January 13, 2025, D. Boral Capital started tracking the stock assigning a Buy rating and target price of $15.
On August 26, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $13.Rodman & Renshaw initiated its Buy rating on August 26, 2024, with a $13 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 31 ’24 when Mistry Erin bought 1,500 shares for $9.99 per share. The transaction valued at 14,985 led to the insider holds 52,011 shares of the business.
Hurlburt Elizabeth sold 140,027 shares of CRMD for $1,565,670 on Nov 14 ’24. The EVP now owns 45,397 shares after completing the transaction at $11.18 per share. On Nov 14 ’24, another insider, Hurlburt Elizabeth, who serves as the Officer of the company, bought 140,027 shares for $11.12 each.
Valuation Measures:
As of this moment, CorMedix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 66.42, and their Forward P/E ratio for the next fiscal year is 8.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.30 while its Price-to-Book (P/B) ratio in mrq is 8.82.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $17.43, while it has fallen to a 52-week low of $3.61. The 50-Day Moving Average of the stock is 27.57%, while the 200-Day Moving Average is calculated to be 47.77%.
Shares Statistics:
A total of 67.71M shares are outstanding, with a floating share count of 65.96M. Insiders hold about 2.75% of the company’s shares, while institutions hold 35.10% stake in the company.
